SCHEMBL29552337

SCHEMBL29552337

O=C(O)c1nnc(Cl)cc1Nc1ccc(OC2CCSCC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 1/20 0.40
▸ EPHX2 P34913 9/20 0.40
▸ FAAH O00519 3/20 0.40
▸ RAF1 P04049 1/20 0.37
▸ DGAT1 O75907 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ LMNA P02545 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CASP3 P42574 1/20 0.35
▸ SENP8 Q96LD8 1/20 0.35
▸ SENP6 Q9GZR1 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ SOAT1 P35610 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29922760 0.89 SYK (0.41) SYKEPHX2FAAHMEN1KMT2A
SCHEMBL28359219 0.89 SYK (0.41) SYKEPHX2FAAHMEN1KMT2A
SCHEMBL29552251 0.81 JAK2 (0.42) EPHX2FAAHDGAT1SOAT1
SCHEMBL29551896 0.75 EHMT2 (0.47) SYKMEN1KMT2ANPC1RAB9A
SCHEMBL29552460 0.72 PARP10 (0.39) SYKEPHX2FAAHDGAT1MEN1
SCHEMBL29552492 0.71 SYK (0.46) SYKMEN1KMT2ANPC1RAB9A
SCHEMBL29552431 0.70 SYK (0.48) SYKMEN1KMT2ANPC1RAB9A
SCHEMBL29553126 0.69 SYK (0.41) SYKEPHX2MEN1KMT2ALMNA
SCHEMBL29552398 0.68 JAK2 (0.54) DGAT1MEN1KMT2ANPC1RAB9A
SCHEMBL19021216 0.67 HCAR3 (0.42) SYKMEN1KMT2AALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
Send feedback